Koyfin Home > Directory > Health Care > Illumina Inc > Capital Expenditures

Illumina Inc Capital Expenditures Chart (ILMN)

Illumina Inc annual/quarterly Capital Expenditures from 2000 to 2018.
  • Illumina Inc Capital Expenditures for the quarter ending September 09, 2018 was $-64m a -18.75% increase of 12m year over year
  • Illumina Inc Capital Expenditures for the last 12 months ending September 09, 2018 was $-307m a -0.98% increase of 3m year over year
  • Illumina Inc Annual Capital Expenditures for 2017 was $-310m a 16.13% decrease of -50m from 2016
  • Illumina Inc Annual Capital Expenditures for 2017 was $-260m a 45.00% decrease of -117m from 2016
  • Illumina Inc Annual Capital Expenditures for 2016 was $-143m a 25.88% decrease of -37m from 2015
Other Cash Flow Metrics:
  • Illumina Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $300m a 15.00% increase of 45m year over year
  • Illumina Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $96m a 128.74% increase of 124m year over year
  • Illumina Inc Total Revenue for the quarter ending December 12, 2018 was $867m a 9.80% increase of 85m year over year
View Chart On Koyfin

Quarterly ILMN Capital Expenditures Data

09/2018$-64m
07/2018$-77m
04/2018$-90m
12/2017$-76m
10/2017$-82m
07/2017$-69m
04/2017$-83m
01/2017$-82m
10/2016$-57m
07/2016$-68m

Annual ILMN Capital Expenditures Data

2017$-310m
2017$-260m
2016$-143m
2014$-106m
2013$-79m
2012$-69m
2012$-78m
2011$-50m
2010$-53m
2008$-60m